BFEC
BIIB icon

Benjamin F. Edwards & Company’s Biogen BIIB Stock Holding History

Benjamin F. Edwards & Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$199K Sell
859
-50
-6% -$10.9K ﹤0.01% 910
2024
Q1 		$196K Sell
909
-22
-2% -$5.15K ﹤0.01% 913
2023
Q4 		$241K Hold
931
– – ﹤0.01% 813
2023
Q3 		$239K Hold
931
– – 0.01% 685
2023
Q2 		$265K Hold
931
– – 0.01% 650
2023
Q1 		$259K Sell
931
-16
-2% -$4.43K 0.01% 642
2022
Q4 		$262K Sell
947
-25
-3% -$7.06K 0.01% 644
2022
Q3 		$260K Sell
972
-103
-10% -$21.9K 0.01% 596
2022
Q2 		$219K Sell
1,075
-161
-13% -$32.9K 0.01% 649
2022
Q1 		$260K Sell
1,236
-113
-8% -$24.6K 0.01% 612
2021
Q4 		$324K Sell
1,349
-1,143
-46% -$294K 0.01% 558
2021
Q3 		$705K Buy
2,492
+135
+6% +$44.2K 0.04% 400
2021
Q2 		$816K Sell
2,357
-307
-12% -$93K 0.04% 365
2021
Q1 		$745K Sell
2,664
-58
-2% -$15.6K 0.04% 382
2020
Q4 		$667K Sell
2,722
-68
-2% -$17.5K 0.04% 374
2020
Q3 		$791K Sell
2,790
-14
-0.5% -$3.9K 0.05% 313
2020
Q2 		$750K Sell
2,804
-68
-2% -$20.4K 0.05% 301
2020
Q1 		$909K Sell
2,872
-246
-8% -$74.7K 0.08% 244
2019
Q4 		$925K Buy
3,118
+40
+1% +$11.1K 0.07% 284
2019
Q3 		$717K Buy
3,078
+2,144
+230% +$499K 0.06% 311
2019
Q2 		$218K Buy
934
+289
+45% +$66.7K 0.02% 509
2019
Q1 		$152K Buy
645
+24
+4% +$7.56K 0.01% 562
2018
Q4 		$187K Sell
621
-20
-3% -$6.38K 0.02% 501
2018
Q3 		$226K Sell
641
-15
-2% -$5.16K 0.02% 501
2018
Q2 		$190K Buy
656
+301
+85% +$84.6K 0.02% 523
2018
Q1 		$97K Sell
355
-193
-35% -$59.9K 0.01% 683
2017
Q4 		$175K Sell
548
-30
-5% -$9.62K 0.02% 513
2017
Q3 		$181K Buy
578
+370
+178% +$110K 0.02% 477
2017
Q2 		$56K Buy
208
+108
+108% +$28.6K 0.01% 688
2017
Q1 		$27K Sell
100
-10
-9% -$2.83K ﹤0.01% 793
2016
Q4 		$31K Buy
110
+10
+10% +$2.96K 0.01% 715
2016
Q3 		$31K Hold
100
– – 0.01% 628
2016
Q2 		$24K Sell
100
-296
-75% -$78K ﹤0.01% 636
2016
Q1 		$103K Sell
396
-255
-39% -$67.4K 0.02% 397
2015
Q4 		$199K Buy
651
+311
+91% +$89.4K 0.04% 308
2015
Q3 		$99K Buy
340
+130
+62% +$42.9K 0.02% 411
2015
Q2 		$85K Hold
210
– – 0.02% 492
2015
Q1 		$89K Hold
210
– – 0.02% 460
2014
Q4 		$71K Hold
210
– – 0.02% 452
2014
Q3 		$69K Hold
210
– – 0.02% 460
2014
Q2 		$66K Hold
210
– – 0.02% 440
2014
Q1 		$64K Sell
210
-12
-5% -$3.81K 0.02% 426
2013
Q4 		$62K Buy
222
+12
+6% +$3.1K 0.02% 402
2013
Q3 		$51K Hold
210
– – 0.02% 402
2013
Q2 		$45K Buy
+210
New +$44.9K 0.02% 378

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Benjamin F. Edwards & Company's BIIB Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Biogen (BIIB) stake by 5.5% in Q2 2024, selling an estimated $10.9K and leaving 859 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #910.

Benjamin F. Edwards & Company first reported a position in BIIB in Q2 2013 and has held it in 45 quarters since. The position peaked at $925K in Q4 2019. 944 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Benjamin F. Edwards & Company held 859 shares of Biogen worth $199K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 50 Biogen shares in Q2 2024, an estimated $10.9K.
  • Biogen made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #910 holding.
  • Benjamin F. Edwards & Company first reported a position in Biogen in Q2 2013 and has held it in 45 quarters since.
  • Benjamin F. Edwards & Company's Biogen position peaked at $925K in Q4 2019.
  • 944 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.